Description
Part I. Introduction to Clinical Exercise Physiology Chapter 1. The Profession of Clinical Exercise Physiology Jonathan K. Ehrman, PhD, Paul M. Gordon, PhD, MPH, Paul S. Visich, PhD, MPH, and Steven J. Keteyian, PhD The Past, Present, and Future of Clinical Exercise Physiology Professional Organizations and Certifications Throughout the World Professionalization of Clinical Exercise Physiology Conclusion Chapter 2. Promoting a Physically Active Lifestyle Anna G. Beaudry, BS, Danielle A. Young, PsyD, and Annie T. Ginty, PhD Benefits of Physical Activity Participation in Regular Physical Activity Conclusion Chapter 3. General Principles of Pharmacology Steven J. Keteyian, PhD General Properties of Drugs Routes of Administration Phases of Drug Effect Mechanism of Action Pharmacotherapy Conclusion Chapter 4. General Interview and Examination Skills Lizbeth R. Brice, MD General Interview Physical Examination Conclusion Chapter 5. Graded Exercise Testing Steven J. Keteyian, PhD Indications Contraindications Procedures for Preparing, Conducting, and Interpreting a Graded Exercise Test Graded Exercise Testing With Diagnostic Imaging Conclusion Chapter 6. Exercise Prescription Steven J. Keteyian, PhD Exercise Training Sequence Goal Setting Principles of Exercise Prescription Cardiorespiratory Endurance Skeletal Muscle Strength and Endurance Flexibility Training Conclusion Chapter 7. Clinical Exercise Programming Jonathan K. Ehrman, PhD Cardiac Rehabilitation Pulmonary Rehabilitation Supervised Exercise Therapy for Patients With Peripheral Artery Disease Cancer Rehabilitation Renal Rehabilitation General Exercise Programs for Patients With Chronic Disease Conclusion Part II. Diseases of the Endocrine System and Metabolic Disorders Chapter 8. Diabetes Sheri R. Colberg, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 9. Obesity David C. Murdy, MD, Dennis J. Kerrigan, PhD, and Jonathan K. Ehrman, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 10. Hypertension Yin Wu, PhD, and Linda S. Pescatello, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 11. Hyperlipidemia and Dyslipidemia Paul G. Davis, PhD, Peter W. Grandjean, PhD, Stephen F. Crouse, PhD, and J. Larry Durstine, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 12. Metabolic Syndrome James R. Churilla, PhD, MPH, MS Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 13. Chronic Kidney Disease Samuel Headley, PhD, Kenneth Wilund, PhD, and Michael Germain, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part III. Diseases of the Cardiovascular System Chapter 14. Acute Coronary Syndromes Ray W. Squires, PhD Pathophysiology Clinical Assessment Exercise Training: Inpatient Cardiac Rehabilitation Exercise Training: Early Outpatient Cardiac Rehabilitation Exercise Prescription Conclusion Chapter 15. Revascularization of the Heart Neil A. Smart, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 16. Chronic Heart Failure Steven J. Keteyian, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 17. Peripheral Artery Disease Ryan J. Mays, PhD, MPH, Ivan P. Casserly, MB, BCh, and Judith G. Regensteiner, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 18. Cardiac Electrical Pathophysiology Kerry J. Stewart, EdD, and David D. Spragg, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Part IV. Diseases of the Respiratory System Chapter 19. Chronic Obstructive Pulmonary Disease Satvir S. Dhillon, MSc, Dennis Jensen, PhD, and Jordan A. Guenette, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 20. Asthma Louis-Philippe Boulet, MD, Simon Bacon, PhD, and Andreanne Cote, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 21. Cystic Fibrosis Kelley Crawford, DPT, CCS Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part V. Diseases of the Immune System and Oncology Chapter 22. Cancer Dennis J. Kerrigan, PhD, and Karen Wonders, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 23. Human Immunodeficiency Virus Vitor H.F. Oliveira, PhD, MS, Christine Horvat Davey, PhD, RN, and Allison R. Webel, PhD, RN Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part VI. Disorders of the Bones and Joints Chapter 24. Arthritis Melissa Nayak, MD, and Andrew K. Cunningham, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 25. Osteoporosis Lora M. Giangregorio, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 26. Nonspecific Low Back Pain Peter Ronai, MS Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Part VII. Disorders of the Neuromuscular System Chapter 27. Spinal Cord Injury Sean M. Tweedy, PhD, Emma M. Beckman, PhD, Mark J. Connick, PhD, Anne L. Hart, PhD, Kati Karinharju, PhD, Kelly M. Clanchy, PhD, and Timothy Geraghty, FAFRM (RACP) Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 28. Multiple Sclerosis Ulrik Dalgas, PhD, and Lars G. Hvid, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 29. Cerebral Palsy Desiree B. Maltais, PT, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 30. Stroke Christopher J. Womack, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Conclusion Chapter 31. Parkinson's Disease Angela L. Ridgel, PhD, and Brandon S. Pollock, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion Part VIII. Special Populations Chapter 32. Children Timothy J. Michael, PhD, and Carol Weideman, PhD Definition Scope Clinical Considerations Exercise Prescription Exercise Training Conclusion Chapter 33. Older Adults Jerome L. Fleg, MD, and Daniel E. Forman, MD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 34. Depression Grace M. McKeon, PhD Candidate, and Simon Rosenbaum, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription and Training Conclusion Chapter 35. Intellectual Disability Tracy Baynard, PhD, and Bo Fernhall, PhD Definition Scope Pathophysiology Clinical Considerations Exercise Prescription Exercise Training Conclusion
Jonathan K. Ehrman, PhD, is the associate program director of preventive cardiology at Henry Ford Hospital in Detroit, where he also serves as chair of the institutional review board. He has a 36-year background in clinical exercise physiology and is certified by the American College of Sports Medicine (ACSM) as a clinical exercise physiologist and as a program director. He previously served as the chair of the clinical exercise physiologist credentialing committee for ACSM. Dr. Ehrman is the author of more than 200 manuscripts and abstracts as well as several textbooks and chapters. He currently serves as editor in chief of the Journal of Clinical Exercise Physiology and was an associate editor of the 10th edition of ACSM's Guidelines for Exercise Testing and Prescription. He is also the coeditor of the sixth edition of the American Association of Cardiovascular and Pulmonary Rehabilitation's Guidelines for Cardiac Rehabilitation Programs. He is a fellow of ACSM and the American Association of Cardiovascular and Pulmonary Rehabilitation and is a member of the American Heart Association and the American College of Cardiology. Dr. Ehrman earned his PhD in clinical exercise physiology from The Ohio State University. Paul M. Gordon, PhD, MPH, is a professor and head of the department of health, human performance, and recreation at Baylor University. He is certified by the American College of Sports Medicine (ACSM) as a clinical exercise physiologist and has over 20 years of experience teaching clinical exercise physiology curricula and directing cardiopulmonary rehabilitation programs. Gordon's areas of expertise include physical activity and lifestyle-based research related to obesity and its comorbidities across the life span. He has published more than 200 papers and abstracts as well as several chapters, including contributions to ACSM's Guidelines for Exercise Testing and Prescription. He has also served as an examiner and coordinator for ACSM certification and credentialing. Dr. Gordon is a fellow of ACSM, the Obesity Society, and the Centers for Disease Control Physical Activity Research Program. He is an international member of the Royal Society of Medicine. He earned his PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh. Paul S. Visich, PhD, MPH, is a professor and chair of the exercise and sports performance department at the University of New England. He has over 20 years of experience in clinical exercise physiology and previously served as director of the Human Performance Laboratory in the College of Health Professions at Central Michigan University. He worked for 12 years in a clinical setting that included cardiac and pulmonary rehabilitation and primary disease prevention. His research interests involve the assessment of cardiovascular disease risk factors in children, the influence of resistance training in elderly populations, and altitude physiology. Dr. Visich previously served as a member of the American College of Sport Medicine (ACSM) exercise physiology credentialing committee and as chair of their professional education committee. He is the author of more than 70 published scientific articles and abstracts. He earned a PhD in exercise physiology and an MPH in epidemiology from the University of Pittsburgh. Steven J. Keteyian, PhD, has more than 40 years of experience working as a clinical exercise physiologist. He is program director of preventive cardiology at the Henry Ford Hospital in Detroit. He is also an adjunct professor in the department of physiology at Wayne State University in Detroit. Over the course of his career, Dr. Keteyian has focused on exercise and physical activity in both healthy individuals and those with chronic diseases. He is the author of more than 250 scientific articles and book chapters, as well as four textbooks, and he previously served as editor in chief for ACSM's Health & Fitness Journal. Dr. Keteyian is a member of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. He earned his PhD from Wayne State University in Detroit.